Anti-aging medicine is the branch of medicine which aims to reduce the chance of developing aging-related arteriosclerosis and other aging-related diseases, including cancer, by intervening in the biological process of aging, and thereby contributing to the extension of a healthy life span.
Due to the COVID-19 pandemic, the global Anti-Aging Medicine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Anti-Aging Medicine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Anti-Aging Medicine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Dermal Fillers accounting for % of the Anti-Aging Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Anti-Aging Medicine include Allergan, Galderma, LG Life Science, Merz Pharma, Medytox, Hugel, IMEIK, Haohai Bio and Daewoong Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Anti-Aging Medicine in 2021.
This report focuses on Anti-Aging Medicine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Anti-Aging Medicine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Anti-Aging Medicine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Dermal Fillers
Botulinum Toxin
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-commerce
Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech